ATLASMEDX, INC.;THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
发明人:
TSANG, TSZE,PETO, CSABA J.,JABLONS, DAVID M.,LEMJABBAR-ALAOUI, HASSAN
申请号：
CA3029004
公开号：
CA3029004A1
申请日:
2017.06.23
申请国别(地区):
CA
年份:
2017
代理人:
摘要：
The application relates to phthalazine derivatives of formula (I) which are inhibitors of PARP1, PARP2 and/or tubulin and thus useful for the treatment of cancer. Also disclosed are pharmaceutical formulations containing such compounds, as well as combinations of these compounds with at least one additional therapeutic agent.
